Industry experts to talk about preparing for success during the COVID-19 landscape and beyond
BOCA RATON, Fla.–(BUSINESS WIRE)–#healthcare—Modernizing Medicine®, a leading healthcare technology company, is hosting a new installment in its thought leadership webinar series. The session, “Urgent COVID-19: Prepare Your Practice for Reopening and the New Normal,” will be held on Tuesday, May 5 at 12 PM EDT. Those interested can register here.
Chief Medical and Strategy Officer at Modernizing Medicine, Michael Sherling, MD, MBA will host the webinar. He echoed the importance of preparing for the new landscape in healthcare and stated, “Although this pandemic has dramatically changed the way we live and how we practice medicine, it has given physicians the opportunity to explore technology like telehealth and patient engagement tools. It’s important to learn how to adjust to the new landscape we will all be facing as healthcare professionals and as patients and take actions now that will have both short- and long-term benefits.”
During the webinar, Matthew McCarthy, MD, assistant professor of medicine at Weill Cornell Medicine and best-selling author of the book, Superbugs: The Race to Stop an Epidemic, will speak to current COVID-19 treatments, where trials are going and how hospitals have been impacted. Dr. McCarthy has been at the epicenter of the crisis and will share his experiences and what medical professionals can do when reopening. He will be joined by James Sweeney, Credit Suisse Chief Economist, who will highlight the current economic landscape, opportunities and the reopening of our country.
Some topics to be discussed during the webinar will include:
Models predict that the coronavirus will ebb and flow for the foreseeable future. Whether those models are completely accurate or not, the new normal in healthcare is here. Medical practices should prepare for the possibility of surges of patients into offices coupled with periods of closing doors and relying heavily on services such as telehealth and other virtual and patient engagement tools. Medical practices will need to be more agile than ever before, whether it’s through a telehealth-enabled EHR system or business services that can help navigate the instability of the times.
If you would like help preparing for reopening and the new normal, please visit www.modmed.com and request more information today.
About Modernizing Medicine
Modernizing Medicine® and its affiliated companies are transforming how healthcare information is created, consumed and utilized in order to increase practice efficiency and improve patient outcomes. Our specialty-specific, data-driven and cloud-based electronic health records (EHR) and practice management (PM) systems, plus revenue cycle management (RCM) services, were built by a team including specialty physicians and practice management professionals. Our suite of products and services is designed to transform the clinical, financial and operational aspects of dermatology, gastroenterology, ophthalmology, orthopedics, otolaryngology, pain management, plastic surgery and urology practices. We also offer products designed specifically for ambulatory surgery centers. For more information, please visit www.modmed.com. Connect with Modernizing Medicine on our Blog, Facebook, LinkedIn and Twitter.
Contacts
For more information, contact:
Modernizing Medicine
Alexandra Bimonte
561-880-2998 x1576
alexandra.bimonte@modmed.com
www.modmed.com
Matter for Modernizing Medicine
Alexandra Foley
978-518-4558
modmed@matternow.com
www.matternow.com
Medical Device Developer & Investor Taps 4 Markets With Growth Projections of USD $39.1B by…
The round is led by Danish VC Dreamcraft, together with biotech investor Lundbeckfonden BioCapital and…
BCC Research Identifies Key Sectors with Substantial Growth Potential, Forecasting Significant Market Expansion Through 2029.…
PALO ALTO, CA / ACCESSWIRE / July 3, 2024 / Bioz, Inc., a pioneering AI…
STOCKHOLM, SWEDEN / ACCESSWIRE / July 3, 2024 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB…
GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza…